Bell John K 4
4 · DelMar Pharmaceuticals, Inc. · Filed May 1, 2019
Insider Transaction Report
Form 4
Bell John K
Director
Transactions
- Disposition to Issuer
Performance Stock Units
2019-04-30−200,000→ 0 totalExp: 2022-07-07→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]Each performance stock unit represents the right to receive one share of common stock, to vest upon achievement of specified targets related to the Company's financial performance. Such performance stock units were unvested.